ACHE and Cognitive impairment: Intracerebroventricular injection of nootkatone (0.02 mg/kg and 0.2 mg/kg) ameliorates Aβ1–42-induced cognitive impairment by upregulating antioxidant and anti-ACHE activities in the hippocampus (He et al., 2018).